| Literature DB >> 29983741 |
Yu Zhang1, Changlei Xia1, Mingming Lu1, Maobing Tu1.
Abstract
BACKGROUND: Biomass prehydrolysates from dilute acid pretreatment contain a considerable amount of fermentable sugars for biofuels production. However, carbonyl degradation compounds present severe toxicity to fermentation microbes. Furans (such as furfural and hydroxymethylfurfural), aliphatic acids (such as acetic acid, formic acid and levulinic acid) and phenolic compounds (such as vanillin and syringaldehyde) have been suggested to be the main inhibitors in biomass prehydrolysates. However, no single compound has been determined as the dominant toxic inhibitor. The effects of various detoxification methods on inhibitors removal have not been fully understood.Entities:
Keywords: Acetone–butanol–ethanol (ABE) fermentation; Carbonyl inhibitors; Detoxification; Prehydrolysates
Year: 2018 PMID: 29983741 PMCID: PMC6020205 DOI: 10.1186/s13068-018-1182-0
Source DB: PubMed Journal: Biotechnol Biofuels ISSN: 1754-6834 Impact factor: 6.040
Fig. 1TIC-GC/MS chromatograms of the prehydrolysates treated with different detoxification methods. a Untreated prehydrolysates, b overliming; c 5% AC; and d sequential overliming and 5% AC
Effect of overliming and AC detoxification on inhibitors removal
| GC peak | Compound name | RTa (min) |
| Inhibitor concentrationb (mg L−1) | ||||
|---|---|---|---|---|---|---|---|---|
| Untreated | Overliming | 5.0% AC | Overliming + 2.5% AC | Overliming + 5.0% AC | ||||
|
| 4444.3 | 1078.6 | 995.1 | 897.3 | 408.7 | |||
| 1* | Furfural | 4.089 | 96 | 3360.9 | 736.8 | 721.8 | 789.3 | 378.4 |
| 2* | 2-Acetylfuran | 5.706 | 110 | 3.3 | 0.9 | 0.9 | 0.9 | 0.8 |
| 5* | 5-Methylfurfural | 6.794 | 110 | 156.3 | 27.5 | 16.8 | 25.3 | 1.9 |
| 7* | Cyclotene | 7.965 | 112 | 3.8 | 1.0 | 1.7 | 0.7 | NA |
| 8** | 2,5-Furandicarboxyaldehyde | 9.063 | 124 | 148.8c | 29.9c | 53.6c | 11.6c | 7.1c |
| 9** | 2-Furyl hydroxymethyl ketone | 9.15 | 126 | 88.4c | 59.5c | 20.3c | 34.1c | 5.9c |
| 10* | 5-Ethylfuran-2-carbaldehyde | 9.226 | 124 | 57.3 | 6.2 | 17.6 | 4.4 | 3.1 |
| 12* | Hydroxymethylfurfural | 12.199 | 126 | 625.5 | 216.8 | 162.4 | 31.0 | 11.6 |
|
| 26.8 | 11.2 | 22.3 | 7.2 | 5.2 | |||
| 3* | 2,5-Hexanedione | 6.094 | 114 | 24.9 | 10.4 | 20.5 | 7.2 | 5.2 |
| 4** | 3-Hexen-2-one | 6.286 | 98 | 1.9d | 0.8d | 1.9d | NA | NA |
|
| 1198.8 | 383.5 | 17.0 | 48.2 | 4.5 | |||
| 6* | Phenol | 7.109 | 94 | 68.2 | 16.7 | 5.3 | 5.1 | 2.7 |
| 11* | Benzoic acid | 11.007 | 122 | 74.9 | 3.8 | 4.7 | 0.4 | NA |
| 13* | 3′-Methoxyacetophenone | 13.211 | 150 | 5.6 | 2.1 | NA | 0.8 | NA |
| 14* | 3,4,5-Trihydroxybenzaldehyde | 13.74 | 154 | 6.4 | 1.7 | 0.4 | 0.2 | NA |
| 15* | Vanillin | 14.458 | 152 | 72.8 | 25.8 | NA | NA | NA |
| 16*** | Homovanillin | 15.263 | 166 | 17.0e | 1.9e | NA | NA | NA |
| 17* | Acetovanillone | 15.636 | 166 | 10.3 | 9.2 | NA | 0.1 | NA |
| 18* | Guaiacylacetone | 16.188 | 180 | 205.5 | 73.5 | 2.0 | 12.8 | 0.9 |
| 19** | 1-(4-Hydroxy-3-methoxyphenyl)propane-1,2-dione | 16.942 | 194 | 121.0e | 20.3e | 2.1e | 4.9e | 0.2e |
| 20*** | 1-(3,4,5-Trihydroxyphenyl)propane-1,2-dione | 17.522 | 196 | 23.1e | 9.8e | 0.2e | 1.0e | NA |
| 21* | Syringaldehyde | 17.826 | 182 | 110.0 | 36.3 | 0.3 | 1.7 | NA |
| 22*** | Hydroxypropiovanillone | 18.189 | 196 | 83.4e | 41.2e | 0.7e | 3.5e | NA |
| 23** | Homosyringaldehyde | 18.29 | 196 | 9.7f | 0.9f | NA | 0.1f | NA |
| 24** | 1-Hydroxy-3-(4-hydroxy-3-methoxyphenyl)propan-2-one | 18.617 | 196 | 0.7e | NA | NA | NA | NA |
| 25* | Acetosyringone | 18.653 | 196 | 57.8 | 27.0 | NA | 0.2 | NA |
| 26* | Syringylacetone | 19.055 | 210 | 88.5 | 29.7 | 0.3 | 9.5 | 0.7 |
| 27* | 1-(4-Hydroxy-3-methoxyphenyl)-2-butanone | 19.142 | 194 | 11.3e | 2.1e | NA | NA | NA |
| 28*** | 1-(4-Hydroxy-3,5-dimethoxyphenyl)propane-1,2-dione | 19.672 | 224 | 104.8f | 15.4f | 0.8f | 5.7f | NA |
| 29*** | 1-Hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-2-propanone | 20.179 | 226 | 6.7f | 4.4f | 0.2f | 0.3f | NA |
| 30*** | 2-Hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)propan-1-one | 20.701 | 226 | 37.5f | 29.2f | NA | 1.5f | NA |
| 31*** | 2-Hydroxy-1-syringyl-ethanone | 21.14 | 226 | 59.7f | 23.7f | NA | 0.4f | NA |
| 32*** | 1-(3,4,5-Trimethoxyphenyl)-1,2-propanedione | 21.517 | 238 | 4.9f | 2.8f | NA | NA | NA |
| 33*** | (4-Hydroxy-3,5-dimethoxybenzoyl)-acetaldehyde | 21.822 | 224 | 9.5f | 0.4f | NA | NA | NA |
| 35*** | 1-(4-Hydroxy-3,5-dimethoxyphenyl)pentane-1,2-dione | 23.388 | 252 | 9.5f | 5.4f | NA | NA | NA |
|
| 45.9 | 14.2 | NA | NA | NA | |||
| 34*** | Gentisein | 22.333 | 244 | 5.6f | 4.0f | NA | NA | NA |
| 36*** | 2-(4-Hydroxy-3-methoxyphenyl)-1-(3,5-dihydroxyphenyl)ethanone | 24.465 | 274 | 2.4f | 1.9f | NA | NA | NA |
| 37*** | 4-Hydroxyphenyl 3,4,5-trimethoxybenzoate | 26.633 | 304 | 4.8f | 2.1f | NA | NA | NA |
| 38*** | 1,2-Bis(4-Hydroxy-3-methoxyphenyl)ethanone | 27.666 | 288 | 5.3f | 2.6f | NA | NA | NA |
| 39*** | 1-(4-Hydroxy-3,5-dimethoxyphenyl)-2-(4-hydroxy-3-methoxyphenyl)ethanon | 29.714 | 318 | 4.5f | 1.1f | NA | NA | NA |
| 40*** | 2-(4-Hydroxy-3,5-dimethoxyphenyl)-1-(4-hydroxy-3-methoxyphenyl)ethanone | 29.725 | 318 | 2.2f | 0.6f | NA | NA | NA |
| 41*** | 2-Syringylacetosyringone | 30.345 | 362 | 2.0f | 0.2f | NA | NA | NA |
| 42*** | Vanillosyringil | 30.748 | 332 | 1.8f | 0.2f | NA | NA | NA |
| 43*** | 1,2-bis(4-Hydroxy-3,5-dimethoxyphenyl)ethanone | 31.397 | 348 | 8.4f | 0.6f | NA | NA | NA |
| 44*** | Syringil | 32.299 | 362 | 1.7f | NA | NA | NA | NA |
| 45*** | 1-(4-Acetyl-3,5-dimethoxyphenyl)-2-(4-hydroxy-3,5-dimethoxyphenyl)ethane-1,2-dione | 34.138 | 388 | 2.3f | 0.9f | NA | NA | NA |
| 46*** | Phenol, 4,4′-(1,2-ethanediyl)bis[2,6-dimethoxy-,diacetate | 36.744 | 418 | 4.9f | NA | NA | NA | NA |
* The compounds verified with standard
** The compounds compared with reference mass spectrum
*** The compounds derived by the fragments
aRT are shortened for the retention time
bInhibitor residual was calculated based on the intergradation area of each compound
cThe concentration was determined by the calibration of hydroxymethylfurfural
dThe concentration was determined by the calibration of 2,5-hexanedione
eThe concentration was determined by the calibration of vanillin
fThe concentration was determined by the calibration of syringaldehyde
Fig. 2Inhibitors composition change of the detoxified prehydrolysates. The inhibitor concentration in the untreated prehydrolysates was assumed as 100%. The percentage were calculated based on the mass concentration in Table 1
Effect of detoxification on organic acid removal
| Compound name | Organic acid removal percentage (%) | ||
|---|---|---|---|
| Overliming | 5.0% AC | Overliming + 5.0% AC | |
|
| |||
| Formic acid | 8.0 | 14.0 | 17.0 |
| Acetic acid | 0.0 | 0.0 | 0.0 |
| Levulinic acid | 5.0 | 6.0 | 10.0 |
|
| |||
| Benzoic acid | 32.2 | 49.5 | 68.2 |
| Cinnamic acid | 74.7 | 100.0 | 100.0 |
| Dihydroxybenzoic acid | 14.0 | 100.0 | 100.0 |
| Coumaric acid | 1.1 | 100.0 | 100.0 |
| Vanillic acid | 32.6 | 85.7 | 93.9 |
| Homovanillic acid | 62.1 | 89.5 | 100.0 |
| Ferulic acid | 60.9 | 100.0 | 100.0 |
| Syringylglycolic acid | 38.8 | 100.0 | 100.0 |
Effect of detoxification on sugar loss and total inhibitor concentrations in the prehydrolysates
| Treatment | Sugar concentration (g L−1) | Total inhibitor concentration (g L−1) | ||||
|---|---|---|---|---|---|---|
| Glucose | Xylose | Galactose | Arabinose | Mannose | ||
| Untreated | 67.85 ± 1.67 | 8.93 ± 0.13 | 1.04 ± 0.10 | 0.64 ± 0.08 | 1.94 ± 0.10 | 5.68 |
| Overliming | 62.98 ± 0.31 | 8.00 ± 0.23 | 0.98 ± 0.11 | 0.56 ± 0.11 | 2.12 ± 0.12 | 1.47 |
| 5.0% AC | 64.85 ± 0.38 | 8.26 ± 0.03 | 0.93 ± 0.05 | 0.61 ± 0.05 | 1.89 ± 0.13 | 1.00 |
| Overliming + 5.0% AC | 62.51 ± 0.28 | 7.84 ± 0.33 | 0.93 ± 0.19 | 0.51 ± 0.05 | 1.89 ± 0.08 | 0.41 |
Effect of detoxification methods on products yield in ABE fermentation
| Sample | Total sugar after fermentationa (g L−1) | |||||
|---|---|---|---|---|---|---|
| Glucose control | 10.28 ± 1.10 | 0.68 ± 0.08 | 11.18 ± 0.03 | 0.25 ± 0.01 | 15.94 ± 0.16 | 0.36 ± 0.02 |
| Untreated | 67.19 ± 0.81 | 6.18 ± 0.21 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
| Overliming | 62.01 ± 1.75 | 6.05 ± 0.19 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
| 5.0% AC | 63.70 ± 1.06 | 6.22 ± 0.17 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
| Overliming + 5.0% AC | 5.89 ± 0.25 | 3.93 ± 0.29 | 13.36 ± 0.35 | 0.22 ± 0.02 | 21.26 ± 0.47 | 0.35 ± 0.09 |
Cacids, represents the final concentration of the acetic acid and butyric acid by 96 h; Cbutanol, represents the butanol production by 96 h; Ybutanol, represents the butanol yield at 96 h based on the total sugar consumption; CABE, represents ABE production by 96 h; YABE, represents the ABE yield at 96 h based on the total sugar consumption
aOriginal sugar concentrations of fermentation were diluted to 90% of the prehydrolysates due to the inoculum of Clostridium. The initial concentration of glucose control was 54.86 g L−1
Fig. 3Effect of sequential detoxification on ABE fermentation of the propolar prehydrolysate. a glucose consumption, b acetone production, c ethanol production, and d butanol production
Effect of overliming on the initial sugar concentrations and yeast fermentations
| Sample | Initial sugar concentration (g L−1) | Total sugar consumptiona (g L−1) | ||||||
|---|---|---|---|---|---|---|---|---|
| Glucose | Xylose | Galactose | Arabinose | Mannose | ||||
| Glucose control | 20.11 ± 0.36 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 20.11 ± 0.36 | 8.32 ± 0.20 | 0.41 ± 0.07 |
| Untreated | 19.94 ± 0.24 | 8.94 ± 0.17 | 1.02 ± 0.04 | 0.68 ± 0.01 | 2.02 ± 0.10 | 1.89 ± 0.13 | 0.00 ± 0.00 | 0.00 ± 0.00 |
| Overliming | 18.76 ± 0.19 | 8.25 ± 0.59 | 0.87 ± 0.02 | 0.67 ± 0.00 | 2.24 ± 0.20 | 24.59 ± 0.16 | 9.82 ± 0.40 | 0.40 ± 0.01 |
aTotal sugar consumption was calculated by the sum of the reduction of five sugars
bCethanol represents the ethanol production by 48 h
cYethanol represents the ethanol yield at 48 h based on the total sugar consumption
Fig. 4Isothermal plots (a) and surface areas of the original, spent and reactivated AC (b)
Fig. 5ABE fermentation of the prehydrolysate detoxified by sequential overliming and reactivated AC. a glucose consumption and ABE production, b ABE production comparison between original AC and reactivated AC detoxification